ADMA Biologics Ownership | Who Owns ADMA Biologics?


OverviewForecastRevenueFinancialsChartTranscripts

ADMA Biologics Ownership Summary


ADMA Biologics is owned by 84.84% institutional investors, 2.57% insiders, and 12.59% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 15.10% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.98% of its assets in ADMA Biologics shares.

ADMA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockADMA Biologics84.84%2.57%12.59%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de36.47M15.10%$664.18M
Blackrock18.64M8.15%$208.45M
Vanguard group18.20M7.76%$312.11M
State street14.87M6.34%$255.03M
Invesco11.30M4.82%$193.73M
Geode capital management5.43M2.32%$93.19M
Morgan stanley4.60M2.01%$51.41M
Dimensional fund advisors lp4.67M1.99%$80.07M
Nuveen asset management4.55M1.94%$78.07M
American century companies4.61M1.91%$83.97M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonepine capital management750.00K13.40%$13.66M
Awm investment company2.20M4.49%$40.06M
Ophir asset management pty1.22M3.61%$22.70M
Palisades investment partners398.65K3.17%$7.26M
Oberweis asset management inc/3.14M2.48%$57.10M
First light asset management952.10K2.25%$17.34M
First turn management684.23K2.10%$11.73M
Lisanti capital growth275.95K1.39%$5.03M
Marathon capital management283.69K1.32%$5.17M
Aubrey capital management189.80K1.25%$3.45M

Top Buyers

HolderShares% AssetsChange
Allspring global investments2.84M0.08%2.61M
State street14.87M0.01%1.87M
T. rowe price investment management1.67M0.02%1.67M
Fmr3.20M0.00%1.25M
First light asset management952.10K2.25%952.10K

Top Sellers

HolderShares% AssetsChange
D. e. shaw3.07M0.04%-2.20M
Bank of montreal /can/26.56K0.00%-2.06M
Nuveen asset management4.55M0.02%-2.03M
Velan capital investment management lp---1.53M
Two sigma advisers, lp2.95M0.12%-1.50M

New Positions

HolderShares% AssetsChangeValue
T. rowe price investment management1.67M0.02%1.67M$30.40M
First light asset management952.10K2.25%952.10K$17.34M
Abrdn531.78K0.02%531.78K$9.68M
Renaissance group343.57K0.24%343.57K$6.26M
Osterweis capital management296.50K0.26%296.50K$5.40M

Sold Out

HolderChange
Mendota financial group-4.00
Corecap advisors-7.00
Global financial private client-24.00
Aquatic capital management-27.00
Stephens consulting-60.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20253764.16%204,872,1710.17%841.15%23018.56%107-6.96%
Mar 31, 20253578.51%204,309,7520.18%851.14%192-4.00%1139.71%
Dec 31, 20243213.55%200,305,365-3.74%851.09%1961.55%992.06%
Sep 30, 202430920.23%208,056,49715.00%881.42%19329.53%9618.52%
Jun 30, 202425517.51%180,834,8813.64%791.33%1497.97%8053.85%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF14.26M5.98%2.05K
Vanguard US Total Market Shares ETF7.15M3.01%281.42K
Vanguard Total Stock Mkt Idx Inv7.17M3.01%-150.89K
iShares Russell 2000 ETF5.46M2.29%-103.74K
SPDR® S&P Biotech ETF3.23M1.35%79.58K
Xtrackers MSCI World Swap ETF 1C2.97M1.24%-
CREF Stock R12.80M1.20%-102.61K
Vanguard Small Cap Index2.75M1.15%-18.30K
American Century Small Cap Growth Inv2.62M1.10%447.92K
American Century U.S. Small Cap Growth2.62M1.10%447.92K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 15, 2025Grossman Adam S President and CEOSell$241.95K
Sep 15, 2025Grossman Adam S President and CEOSell$96.78K
Aug 15, 2025Grossman Adam S President and CEOSell$101.28K
Aug 15, 2025Grossman Adam S President and CEOSell$253.20K
Jul 15, 2025Grossman Adam S President and CEOSell$111.96K

Insider Transactions Trends


DateBuySell
2025 Q3-6
2025 Q2-13
2025 Q1-2
2024 Q4-2
2024 Q3-6

ADMA Ownership FAQ


Who Owns ADMA Biologics?

ADMA Biologics shareholders are primarily institutional investors at 84.84%, followed by 2.57% insiders and 12.59% retail investors. The average institutional ownership in ADMA Biologics's industry, Biotech Stocks , is 306.59%, which ADMA Biologics falls below.

Who owns the most shares of ADMA Biologics?

ADMA Biologics’s largest shareholders are Blackrock funding, inc. /de (36.47M shares, 15.10%), Blackrock (18.64M shares, 8.15%), and Vanguard group (18.2M shares, 7.76%). Together, they hold 31.01% of ADMA Biologics’s total shares outstanding.

Does Blackrock own ADMA Biologics?

Yes, BlackRock owns 8.15% of ADMA Biologics, totaling 18.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 208.45M$. In the last quarter, BlackRock increased its holdings by 445.43K shares, a 2.45% change.

Who is ADMA Biologics’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is ADMA Biologics’s biggest shareholder by percentage of total assets invested, with 13.40% of its assets in 750K ADMA Biologics shares, valued at 13.66M$.

Who is the top mutual fund holder of ADMA Biologics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ADMA Biologics shares, with 5.98% of its total shares outstanding invested in 14.26M ADMA Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools